Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$ADMA Biologics(ADMA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-24-025226 Act: 34 Size: 7 MB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-24-025173 Act: 34 Size: 442 KB 网页链接
$ADMA Biologics(ADMA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-019869 Act: 34 Size: 2 MB 网页链接
$ADMA Biologics(ADMA)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-019876 Act: 34 Size: 3 MB 网页链接
$ADMA Biologics(ADMA)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-019868 Act: 34 Size: 2 MB 网页链接
$ADMA Biologics(ADMA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-24-017372 Size: 33 KB 网页链接
$ADMA Biologics(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-017376 Size: 17 KB 网页链接
$ADMA Biologics(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-017377 Size: 9 KB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001140361-24-017331 Act: 34 Size: 299 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-014226 Size: 8 KB 网页链接